| Dr Abraham Kuruvilla, PHARMD | |
|
960 North Ave, Bridgeport, CT 06606-5750 | |
| (203) 334-6978 | |
| (203) 334-8280 |
| Full Name | Dr Abraham Kuruvilla |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 960 North Ave, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417239153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PCT.0011029 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Abraham Kuruvilla, PHARMD 960 North Ave, Bridgeport, CT 06606-5750 Ph: (203) 334-6978 | Dr Abraham Kuruvilla, PHARMD 960 North Ave, Bridgeport, CT 06606-5750 Ph: (203) 334-6978 |
News Archive
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has entered into a research and exclusive license agreement with Teva Pharmaceutical Industries Ltd. to develop and commercialize XMT-1107, a novel fumagillin analog, for the treatment of all indications, including cancer.
Vertex Pharmaceuticals Incorporated today announced a modification of its Phase 2 clinical trial evaluating 12-week, response-guided regimens of its lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for its newest product, the Glider™ balloon catheter, for percutaneous transluminal angioplasty (PTA) of lesions in the peripheral vasculature including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries.
Repligen Corporation today reported results for the first quarter of fiscal year 2011, ended June 30, 2010. Total revenue for the first quarter was $7,010,000 compared to total revenue of $5,061,000 for the first quarter of fiscal year 2010, an increase of $1,949,000 or 39%. Bioprocessing product revenue for the first quarter was $4,269,000 compared to $2,473,000 for the first quarter of fiscal 2010, an increase of $1,796,000 or 73%.
COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).
› Verified 8 days ago
Dr. Yeganeh Ragati Haghi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1060 E Main St, Bridgeport, CT 06608 Phone: 203-382-0009 | |
Yujin Hong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4531 Main St, Bridgeport, CT 06606 Phone: 203-372-6538 Fax: 844-411-6470 | |
Ju-sung Song, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 960 North Ave, Bridgeport, CT 06606 Phone: 203-334-6978 | |
Dr. Lena Devietro, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3252 | |
Paul Joseph Piazza, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3252 Fax: 203-384-3625 | |
Dr. Lauren Michelle Dietrich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-6227 | |
Kevin Ehl, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Park Ave, Bridgeport, CT 06604 Phone: 203-696-0127 |